All terms in HP
Label | Id | Description |
---|---|---|
ornithinate | CHEBI_32964 | |
ornithinium(1+) | CHEBI_46912 | |
Acute bronchitis | HP_0012388 | [Inflammation of the large airways of the lung with rapid onset and short course usually associated with cough, mucus production, shortness of breath, wheezing, and chest tightness.] |
N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide | CHEBI_18259 | [A glycotetraosylceramide having N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucose as the tetrasaccharide component.] |
N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide | CHEBI_88167 | [A glycotetraosylceramide having N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl component attached to the primary hydroxy function of a ceramide with undefined sphingoid base.] |
alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-yl group | CHEBI_142567 | [A trisaccharide beta-D-glucosyl group obtained by removal of the hydroxy group from the hemiacetal function of alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucose. Part of, and the proposed epitope from, alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide (globoside Gb3Cer; globotriosylceramide; CTH).] |
->4)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-yl group | CHEBI_142533 | [An organic group forming part of, and a proposed epitope within, globoside GM1.] |
antigen | CHEBI_59132 | [Any substance that stimulates an immune response in the body, such as through antibody production or by presentation to a T-cell receptor after binding to a major histocompability complex (MHC).] |
Absent hallux | HP_0012386 | [Aplasia of the hallux, that is, a development defect such that the big toe does not develop.] |
Aplasia/Hypoplasia of the hallux | HP_0008362 | [Absence or underdevelopment of the big toe.] |
3,3',5-triiodo-L-thyronine | CHEBI_18258 | [An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.] |
iodophenol | CHEBI_24863 | |
iodothyronine | CHEBI_24864 | [An iodoamino acid in which the amino acid specified is thyronine.] |
2-halophenol | CHEBI_53291 | [A halophenol in which the halogen atom is bonded to the carbon atom adjacent to the C-OH group.] |
3,3',5-triiodo-L-thyroninate | CHEBI_60308 | [The anion resulting from the removal of the proton from the carboxylic acid group of 3,3',5-triiodo-L-thyronine.] |
3,3',5-triiodo-L-thyronine zwitterion | CHEBI_533015 | [The amino acid zwitterion formed from 3,3',5-triiodo-L-thyronine by tranfer of a proton from the carboxy group to the amino group. It is the major species at pH 7.3.] |
thyroid hormone | CHEBI_60311 | [Any hormone produced by the thyroid gland] |
Camptodactyly | HP_0012385 | [The distal interphalangeal joint and/or the proximal interphalangeal joint of the fingers or toes cannot be extended to 180 degrees by either active or passive extension.] |
Flexion contracture of digit | HP_0030044 | [A bent (flexed) finger or toe joint that cannot be straightened actively or passively. It is thus a chronic loss of joint motion due to structural changes in muscle, tendons, ligaments, or skin that prevents normal movement of joints.] |
IgM immunoglobulin complex, circulating | GO_0071754 | [A polymer of five or six IgM core units each composed of two identical immunoglobulin heavy chains of the IgM isotype and two identical immunoglobulin light chains, held together by disulfide bonds; the individual IgM core units are held together via disulfide bonds with a single J chain polypeptide acting as a bridge between two of the polymeric units. Circulating IgM is present in the extracellular space, in mucosal areas or other tissues, or in the blood or lymph.] |